|
1
|
Beasley RP: Hepatitis B virus. The major
etiology of hepatocellular carcinoma. Cancer. 61:1942–1956. 1998.
View Article : Google Scholar
|
|
2
|
Papatheodoridis GV, Lampertico P,
Manolakopoulos S and Lok A: Incidence of hepatocellular carcinoma
in chronic hepatitis B patients receiving nucleos(t)ide therapy: a
systematic review. J Hepatol. 53:348–356. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan X, Fang D, Bin D, Xueyong L, Jun C and
Hongshan W: Serum levels of surface large envelope protein:
prognostic marker for hepatitis B e antigen-negative patients with
adefovir dipivoxil treatment. Antivir Ther. 14:1149–1156. 2009.
View Article : Google Scholar
|
|
4
|
Wong DK, Yuen MF, Poon RT, Yuen JC, Fung J
and Lai CL: Quantification of hepatitis B virus covalently closed
circular DNA in patients with hepatocellular carcinoma. J Hepatol.
45:553–559. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barone M, Daniela Spano D, D'Apolito M,
Centra M, Lasalandra C, Capasso M, Di Leo A, Volinia S, Arcelli D,
Rosso N, Francavilla A, Tiribelli C and Iolascon A: Gene expression
analysis in HBV transgenic mouse liver: a model to study early
events related to hepatocarcinogenesis. Mol Med. 12:115–123. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ehebauer M, Hayward P and Arias AM: Notch,
a universal arbiter of cell fate decisions. Science. 314:1414–1415.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Louis AA, Van Eyken P, Haber BA, Hicks C,
Weinmaster G, Taub R and Rand EB: Hepatic jagged1 expression
studies. Hepatology. 30:1269–1275. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Geisler F, Nagl F, Mazur PK, Lee M,
Zimber-Strobl U, Strobl LJ, Radtke F, Schmid RM and Siveke JT:
Liver-specific inactivation of Notch2, but not Notch1, compromises
intrahepatic bile duct development in mice. Hepatology. 48:607–616.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuan ZR, Kobayashi N and Kohsaka T: Human
Jagged 1 mutants cause liver defect in Alagille syndrome by
overexpression of hepatocyte growth factor. J Mol Biol.
356:559–568. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nijjar SS, Wallace L, Crosby HA, Hubscher
SG and Strain AJ: Altered Notch ligand expression in human liver
disease: further evidence for a role of the Notch signaling pathway
in hepatic neovascularization and biliary ductular defects. Am J
Pathol. 160:1695–1703. 2002. View Article : Google Scholar
|
|
11
|
Gramantieri L, Giovannini C, Lanzi A,
Chieco P, Ravaioli M, Venturi A, Grazi GL and Bolondi L: Aberrant
Notch3 and Notch4 expression in human hepatocellular carcinoma.
Liver Int. 27:997–1007. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Siegel AB, Olsen SK, Magun A and Brown RS
Jr: Sorafenib: where do we go from here? Hepatology. 52:360–369.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li GL, Wei HS, Song SJ, Guo J and Cheng J:
The effects of angiotensin II on gene expression of hepatic
stellate cells. Zhonghua Gan Zang Bing Za Zhi. 14:914–919. 2006.(In
Chinese).
|
|
14
|
Gutiérrez Gallego R, Haseley SR, van
Miegem VF, Vliegenthart JF and Kamerling JP: Identification of
carbohydrates binding to lectins by using surface plasmon resonance
in combination with HPLC profiling. Glycobiology. 14:373–386.
2004.PubMed/NCBI
|
|
15
|
Chen X, Kintner DB, Luo J, Baba A, Matsuda
T and Sun D: Endoplasmic reticulum Ca2+ dysregulation
and endoplasmic reticulum stress following in vitro neuronal
ischemia: role of Na+-K+-Cl−
cotransporter. J Neurochem. 106:1563–1576. 2008.
|
|
16
|
Shuda M, Kondoh N, Imazeki N, Tanaka K,
Okada T, Mori K, Hada A, Arai M, Wakatsuki T, Matsubara O, Yamamoto
N and Yamamoto M: Activation of the ATF6, XBP1 and grp78 genes in
human hepatocellular carcinoma: a possible involvement of the ER
stress pathway in hepatocarcinogenesis. J Hepatol. 38:605–614.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Arai M, Kondoh N, Imazeki N, Hada A,
Hatsuse K, Kimura F, Matsubara O, Mori K, Wakatsuki T and Yamamoto
M: Transformation-associated gene regulation by ATF6alpha during
hepatocarcinogenesis. FEBS Lett. 580:184–190. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao J, Song Z, Chen Y, Xia L, Wang J, Fan
R, Du R, Zhang F, Hong L, Song J, Zou X, Xu H, Zheng G, Liu J and
Fan D: Deregulated expression of Notch receptors in human
hepatocellular carcinoma. Dig Liver Dis. 40:114–121. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Giovannini C, Lacchini M, Gramantieri L,
Chieco P and Bolondi L: Notch3 intracellular domain accumulates in
HepG2 cell line. Anticancer Res. 26:2123–2127. 2006.PubMed/NCBI
|
|
20
|
Xu HY, Li BJ, Wang RF and Andersson R:
Alterations of Notch/Jagged mRNA and protein expression after
partial hepatectomy in rats. Scand J Gastroenterol. 43:1522–1528.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Monsalve E, Ruiz-García A, Baladrón V,
Ruiz-Hidalgo MJ, Sánchez-Solana B, Rivero S, García-Ramírez JJ,
Rubio A, Laborda J and Díaz-Guerra MJ: Notch1 upregulates
LPS-induced macrophage activation by increasing NF-kappaB activity.
Eur J Immunol. 39:2556–2570. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Itoh M, Fu L and Tohda S: NF-κB activation
induced by Notch ligand stimulation in acute myeloid leukemia
cells. Oncol Rep. 22:631–634. 2009.
|
|
23
|
Nevzorova YA, Tschaharganeh D, Gassler N,
Geng Y, Weiskirchen R, Sicinski P, Trautwein C and Liedtke C:
Aberrant cell cycle progression and endoreplication in regenerating
livers of mice that lack a single E-type cyclin. Gastroenterology.
137:691–703. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cho JW, Lee KS and Kim CW: Curcumin
attenuates the expression of IL-1β, IL-6, and TNF-α as well as
cyclin E in TNF-α-treated HaCaT cells; NF-κB and MAPKs as potential
upstream targets. Int J Mol Med. 19:469–474. 2007.
|
|
25
|
Morga E, Mouad-Amazzal L, Felten P,
Heurtaux T, Moro M, Michelucci A, Gabel S, Grandbarbe L and
Heuschling P: Jagged1 regulates the activation of astrocytes via
modulation of NFkappaB and JAK/STAT/SOCS pathways. Glia.
57:1741–1753. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feng B, Cheng S, Hsia CY, King LB, Monroe
JG and Liou HC: NF-kappaB inducible genes BCL-X and cyclin E
promote immature B-cell proliferation and survival. Cell Immunol.
232:9–20. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bharti AC, Takada Y, Shishodia S and
Aggarwal BB: Evidence that receptor activator of nuclear factor
(NF)-kappaB ligand can suppress cell proliferation and induce
apoptosis through activation of a NF-kappaB-independent and
TRAF6-dependent mechanism. J Biol Chem. 279:6065–6076. 2004.
View Article : Google Scholar
|
|
28
|
Chen E and Li CC: Association of
Cdk2/cyclin E and NF-kappa B complexes at G1/S phase. Biochem
Biophys Res Commun. 249:728–734. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pujol MJ, Jaime M, Serratosa J, Jaumot M,
Agell N and Bachs O: Differential association of p21Cip1 and
p27Kip1 with cyclin E-CDK2 during rat liver regeneration. J
Hepatol. 33:266–274. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Koroxenidou L, Ohlson LC and Porsch
Hällström I: Long-term 17alpha-ethinyl estradiol treatment
decreases cyclin E and cdk2 expression, reduces cdk2 kinase
activity and inhibits S phase entry in regenerating rat liver. J
Hepatol. 43:478–484. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin SS, Huang HP, Yang JS, Wu JY, Hsia TC,
Lin CC, Lin CW, Kuo CL, Gibson Wood W and Chung JG: DNA damage and
endoplasmic reticulum stress mediated curcumin-induced cell cycle
arrest and apoptosis in human lung carcinoma A-549 cells through
the activation of caspase cascade- and mitochondrial-dependent
pathway. Cancer Lett. 272:77–90. 2008. View Article : Google Scholar
|
|
32
|
Derkx PM and Madrid SM: The foldase CYPB
is a component of the secretory pathway of Aspergillus niger
and contains the endoplasmic reticulum retention signal HEEL. Mol
Genet Genomics. 266:537–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
